Upload Avatar (500 x 500)
Xinhui Su
suxinhui@zju.edu.cn
Chinese, English
Zhejiang
Zhejiang University
Medical
  • Multiple Fujian Science and Technology Progress Awards
  • Published over 60 articles
  • Fujian Medical Science and Technology Award (2018): Second Prize
  • Fujian Science and Technology Progress Award (2019): Second Prize
  • Xiamen Science and Technology Progress Award (2018): Second Prize
  • Fujian Medical Science and Technology Award (2017): Third Prize
  • Fujian Science and Technology Progress Award (2017): Third Prize
  • Xiamen Outstanding Talent (2019)
  • Xiamen Advanced Individual in Science, Technology, and Health Work (2018)
  • Xiamen Top Talent (2018)
  • Xiamen Leading Talent (2018)
  • Advanced Individual for BRICS Summit Preparation and Service (2017)
  • Xiamen University Medical School Advanced Individual in Scientific Research (2016)
PET/CT imaging: molecular imaging, nuclear medicine, clinical research, radiopharmaceuticals, diagnostic imaging, oncology, radiology, imaging techniques, medical imaging, PET/CT
Development and application of radionuclide probes: radionuclide, probe development, clinical application, nuclear medicine, molecular imaging, diagnostic tools, radiopharmaceuticals, imaging agents, biomedical research, probe synthesis
Synthesis and biological application of sugar-targeted formulations: sugar-targeted, formulation synthesis, biological application, molecular imaging, diagnostic imaging, oncology, radiopharmaceuticals, imaging agents, biomedical research, targeted therapy
  • A fluorescence-activatable tumor-reporting probe for precise photodynamic therapy, Li J, Wang T, Jiang F, Hong Z, Su X (#), Li S (#), Han S (#), 2021
  • Activatable Dual ROS-Producing Probe for Dual Organelle-Engaged Photodynamic Therapy, Li J, Wang T, Jiang F, Hong Z, Su X (#), Li S (#), Han S (#), 2021
  • Hypoxia-Activated Prodrug Enabling Synchronous Chemotherapy and HIF-1α Downregulation for Tumor Treatment, Luo X, Li A, Chi X, Lin Y, Liu X, Zhang L, Su X, Yin Z, Lin H, Gao J, 2021
  • TSPO靶向分子探针CB86-DTPA-GD的制备及类风湿关节炎模型MRI研究, 侯振宇, 王婷婷, 苏新辉 (#), 郭志德, 王强, 吴环华, 马超, 苏福, 2021
  • Radioiodinated Persistent Luminescence Nanoplatform for Radiation-Induced Photodynamic Therapy and Radiotherapy, Wang Q, Liu N, Hou Z, Shi J (#), Su X (#), Sun X (#), 2021
  • In Vivo Repeatedly Activated Persistent Luminescence Nanoparticles by Radiopharmaceuticals for Long-Lasting Tumor Optical Imaging, Liu N, Shi J, Wang Q, Guo J, Hou Z, Su X (#), Zhang H (#), Sun X (#), 2020
  • Preclinical Evaluation of a Novel 99mTc-Labeled CB86 for Rheumatoid Arthritis Imaging, Liu P, Wang T, Yang R, Dong W, Wang Q, Guo Z, Ma C, Wang W (#), Li H (#), Su X (#), 2020
  • Organelle-Partitioned Sugar-Rhodamine Diad for In Vivo Tumor Imaging, Zhang E, Yu C, Tang H, Li Y, Zuo D, Yang R, Ma C, Miao J (#), Liu P (#), Su X (#), 2020
  • Imaging stressed organelles via sugar-conjugated color-switchable pH sensors, Zhang E, Wang S, Su X (#), Han S (#), 2020
  • Gadolinium-conjugated CB86: a novel TSPO-targeting MRI contrast agent for imaging of rheumatoid arthritis, Hou Z, Wang Q, Guo Z, Wang T, Wu H, Ma C, Wang W, Su F (#), Zhang H (#), Su X (#), 2020
  • High HbA level is correlated with blood-brain barrier disruption in syphilis patients, Wang F (*), Ge H (*), Su X (*), Wang R, Zeng J, Miao J, 2020
  • Optimal Saturated Neuropilin-1 Expression in Normal Tissue Maximizes Tumor Exposure to Anti-Neuropilin-1 Monoclonal Antibody, Ma C, Dou X, Yan J, Wang S, Yang R, Su F (#), Zhang H (#), Su X (#), 2019
  • Acute multiple organ dysfunction caused by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults: a case report and literature review, Su F, Yang R, Ma C, Chen G, Huang M, Wang W, Su X (#), 2019
  • Radioiodinated progesterone derivative for progesterone receptor targeting with enhanced nucleus uptake via phenylboronic acid conjugation, Gao F, Peng C, Li J, Zhuang R, Guo Z, Xu D, Su X (#), Zhang X (#), 2019
  • 靶向TSPO显像剂18F-VUIIS1008的制备及其对类风湿关节炎模型的显像, 王亮亮, 侯振宇, 苏新辉 (#), 吴环华, 王强, 董文涛, 陈丽春, 郭志德, 马超, 苏福, 2019
  • SPECT imaging of TSPO expression in rat myocardial-infarction-reperfusion models with Tc-99(m)-labeled TSPO ligand CB86, Su F, Dong Wen, Li J, Guo Z, Su X (*), 2019
  • Preparation and imaging of arthritis of Tc-99(m)-DTPA-CB86 for TSPO targeted imaging, Su X (*), Liu P, Dong W, Guo Z, Ma C, 2018
  • Preparation and biological evaluation of F-18-VUIIS1008 for TSPO targeted imaging, Ma C, Wang L, Dong W, Guo Z, Su X (#), 2018
  • Synthesis of a new coumarin dye for pH independent staining of, Zhu R, Wang S, Su X (#), Liu J (#), 2018
  • Liposome-aided metabolic engineering of tumor surface immunogenicity, Zheng N, Wang S, Su X (#), Han S (#), 2018
  • Neural Stem Cells Alleviate Inflammation via Neutralization of IFN-γ Negative Effect in Ischemic Stroke Model, Zhang G, Chen L (#), Chen W, Li B, Yu Y, Lin F, Guo X, Wang H, Wu G, Gu B, Miao W, Kong J, Jin X, Yi G, You Y, Su X (#), Gu N, 2018
  • Comparative Analysis of microRNA Expression Profiles of Exosomes Derived from Normal and Hypoxic Preconditioning Human Neural Stem Cells by Next Generation Sequencing, Zhang G, Chen L (#), Guo X, Wang H, Chen W, Wu G, Gu B, Miao W, Kong J, Jin X, Yi G, You Y, Su X (#), Gu N, 2018
  • Inflammatory myofibroblastic tumor mimicking lymphoma on 18F-FDG PET/CT. Report of a case and review of the literature, Ma C, Lu J, Chen G, Wang W, Su F (#), Su X (#), 2018
  • miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis, Zhang G, Chen L (#), Khan AA, Li B, Gu B, Lin F, Su X (#), Yan J, 2018
  • 靶向TSPO显像剂99Tcm-DTPA-CB86的制备及其对关节炎症的SPECT/CT显像研究, 刘鹏, 董文涛, 苏新辉(#), 黄剑全, 王亮亮, 蒋怡臻, 郭志德, 马超, 苏福, 2018
  • 131I标记抗神经纤毛蛋白-2单克隆抗在荷肺腺癌裸鼠中的生物分布及显像
Molecular Imaging Nuclear Medicine Clinical Research Radiopharmaceuticals Diagnostic Imaging Oncology Radiology Imaging Techniques Medical Imaging Pet/Ct Radionuclide Probe Development Clinical Application Diagnostic Tools Imaging Agents Biomedical Research Probe Synthesis Sugar-Targeted Formulation Synthesis Biological Application Targeted Therapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.